科研级 Lenvervimab, Anti-HBV Recombinant Antibody, Research Grade Lenvervimab
Molecular Name
Lenvervimab
Size
1mg, 5mg
CAS Number
2055006-79-4
Isotype
IgG1 Kappa
Clonality
Monoclonal
Concentration
1mg/ml
Source
CHO Cells
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Target
HBV[Homo sapiens]
Background
Lenvervimab (INN, development code GC1102) is a monoclonal antibody that is being investigated for hepatitis B. This drug is being developed by GC Pharma. As of 2018, lenvervimab is undergoing Phase II/III trials.